These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Ironic case of hepatic dysfunction following the global withdrawal of sitaxentan. Don GW; Joseph F; Celermajer DS; Corte TJ Intern Med J; 2012 Dec; 42(12):1351-4. PubMed ID: 23253000 [TBL] [Abstract][Full Text] [Related]
6. [Endothelin receptor antagonists in the new European guidelines on pulmonary hypertension]. Montani D; Humbert M Rev Mal Respir; 2010 Feb; 27(2):103-5. PubMed ID: 20206056 [No Abstract] [Full Text] [Related]
7. Successful up-front combination therapy in a patient with idiopathic pulmonary hypertension and patent foramen ovale: an alternative to epoprostenol therapy? Pitsiou GG; Chavouzis N; Nakou C; Boutou AK; Argyropoulou P; Stanopoulos I J Heart Lung Transplant; 2009 Jun; 28(6):651-3. PubMed ID: 19481029 [TBL] [Abstract][Full Text] [Related]
8. Pulmonary arterial hypertension occurrence after liver transplant in systemic sclerosis: a report of 2 cases sustainably treated by sildenafil. Koumakis E; Wipff J; Kahan A; Allanore Y Clin Exp Rheumatol; 2010; 28(2 Suppl 58):S53-4. PubMed ID: 20576215 [TBL] [Abstract][Full Text] [Related]
13. Exacerbation of AIH in a patient with an AIH/systemic sclerosis overlap syndrome and pulmonary arterial hypertension treated with the endothelin-1 receptor antagonist sitaxentan. Klein R; Hintz E; Staehler G BMJ Case Rep; 2012 Jul; 2012():. PubMed ID: 22802555 [TBL] [Abstract][Full Text] [Related]
14. Oral Therapies for the treatment of pulmonary arterial hypertension: a population-based cost-minimization analysis. Lefebvre MC; Hunsche E Appl Health Econ Health Policy; 2010; 8(1):69-71; author reply 71-3. PubMed ID: 20238466 [No Abstract] [Full Text] [Related]
15. [Specific drugs for the treatment of pulmonary arterial hypertension - current status]. Stähler G Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S183-6. PubMed ID: 18814092 [TBL] [Abstract][Full Text] [Related]
16. An evidence-based approach to the management of pulmonary arterial hypertension. Archer SL; Michelakis ED Curr Opin Cardiol; 2006 Jul; 21(4):385-92. PubMed ID: 16755209 [TBL] [Abstract][Full Text] [Related]